GlaxoSmithKline CR`s Cost of Financing reached 1.42 % in 2014. This is 27 % less than in the previous year.
Buy Cost of Financing data for GlaxoSmithKline Czech Republic.
$19.99Buy all data for GlaxoSmithKline Czech Republic.
Buy annual subscriptions for all our products.
Company | Unit | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
Amgen Czech Republic | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 1,890 | 11.3 | 0.592 | ... | |
Bayer Czech Republic | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 11.0 | 6.28 | 1.76 | ||||
GlaxoSmithKline Czech Republic | % | ... | ... | ... | 1.64 | 1.09 | 1.94 | 1.42 | ... | ... | ... | |||||||
Merck Czech Republic | % | ... | ... | 4.81 | 8.10 | 4.56 | 7.78 | 68.8 | ... | ... | ||||||||
Novartis Czech Republic | % | 2.97 | 10.8 | 36.9 | 17.3 | 12.1 | ||||||||||||
Pfizer Czech Republic | % | ... | ... | ... | ... | 4.09 | 0.877 | ... | ... | ... | ... | |||||||
Roche Czech Republic | % | ... | ... | ... | 0.316 | -2.24 | 0.681 | 0.272 | 0.136 | ... | ||||||||
Sanofi-Aventis Czech Republic | % | ... | ... | ... | ... | 1.59 | 1.50 | 0.956 | 1.24 | 0.511 | ||||||||
Walmark | % | ... | ... | ... | 6.80 | 7.39 | 4.30 | 5.04 | 34.6 |